Sudden death in patients with Implantable Cardioverter defibrillators - The importance of post-shock electromechanical dissociation

被引:151
作者
Mitchell, LB
Pineda, EA
Titus, JL
Bartosch, PM
Benditt, DG
机构
[1] Univ Calgary, Foothills Hosp, NW Calgary, AB T2N 2T9, Canada
[2] Cardiac Surg Associates, Minneapolis, MN USA
[3] Univ Minnesota, Minneapolis, MN USA
[4] Medtronic Inc, Minneapolis, MN USA
[5] United Hosp, Jesse E Edwards Registry Cardiovasc Dis, St Paul, MN USA
关键词
D O I
10.1016/S0735-1097(02)01784-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The purpose of this study was to determine the mechanisms of sudden death (SD) in patients with ventricular tachyarrhythmias (ventricular tachycardia/ventricular fibrillation [VT/VF]) treated with an implantable e cardioverter defibrillator (ICD). BACKGROUND Despite ICD therapy, some patients with VT/VF still die suddenly. Optimal ICD use requires determination of the mechanisms of these residual SDs. METHODS We reviewed 320 patient deaths during trials of Medtronic transvenous lCD systems (Medtronic Inc., Minneapolis, Minnesota). Sudden deaths were further categorized according to mechanism. Post-shock electromechanical dissociation (EMD) describes a scenario where VT/VF was appropriately detected and treated by an ICD shock that restored a physiologic rhythm, but death still occurred immediately v EMD. RESULTS A mode of death could be ascribed for 317 patients-90 (29%) were sudden, 156 (49%) were nonsudden cardiac, and 71 (22%) were noncardiac. A mechanism of SD was proposed for 68 patients-20 (29%) had post-shock EMD, 17 (25%) had VT/VF uncorrected by shocks, 11 (16%) had primary, electromechanical dissociation, 9 (13%) had incessant VT/VF, 5 (7%) had VT/VF after their ICD was deactivated or removed, and 6 (9%) had single instances of various other terminal events. Only New York Heart Association functional class independently predicted S by post-shock EMD. CONCLUSIONS The most common mechanism of SD in patients with an ICD is VT/VF treated with an appropriate shock followed by EMD. As this mechanism accounted for 29% of the SDs to which a cause could be ascribed, this mechanism of SD warrants further investigation. (J Am Coll Cardiol 2002;39:1323-8) (C) 2002 by the American College of Cardiology Foundation.
引用
收藏
页码:1323 / 1328
页数:6
相关论文
共 58 条
  • [1] AKHTAR M, 1992, CIRCULATION, V85, P131
  • [2] AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR DISCHARGES AND ACUTE MYOCARDIAL INJURY
    AVITALL, B
    PORT, S
    GAL, R
    MCKINNIE, J
    TCHOU, P
    JAZAYERI, M
    TROUP, P
    AKHTAR, M
    [J]. CIRCULATION, 1990, 81 (05) : 1482 - 1487
  • [3] SURVIVAL IN PATIENTS WITH DEPRESSED LEFT-VENTRICULAR FUNCTION TREATED BY IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
    AXTELL, K
    TCHOU, P
    AKHTAR, M
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1991, 14 (02): : 291 - 296
  • [4] THERAPEUTIC INDEXES FOR TRANSCHEST DEFIBRILLATOR SHOCKS - EFFECTIVE, DAMAGING, AND LETHAL ELECTRICAL DOSES
    BABBS, CF
    TACKER, WA
    VANVLEET, JF
    BOURLAND, JD
    GEDDES, LA
    [J]. AMERICAN HEART JOURNAL, 1980, 99 (06) : 734 - 738
  • [5] CLINICAL-EXPERIENCE WITH A TIERED-THERAPY, MULTIPROGRAMMABLE ANTIARRHYTHMIA DEVICE
    BARDY, GH
    TROUTMAN, C
    POOLE, JE
    KUDENCHUK, PJ
    DOLACK, GL
    JOHNSON, G
    HOFER, B
    [J]. CIRCULATION, 1992, 85 (05) : 1689 - 1698
  • [6] COBB LA, 1975, CIRCULATION, V52, P223
  • [7] Canadian implantable defibrillator study (CIDS) - A randomized trial of the implantable cardioverter defibrillator against amiodarone
    Connolly, SJ
    Gent, M
    Roberts, RS
    Dorian, P
    Roy, D
    Sheldon, RS
    Mitchell, LB
    Green, MS
    Klein, GJ
    O'Brien, B
    [J]. CIRCULATION, 2000, 101 (11) : 1297 - 1302
  • [8] CLINICAL-EXPERIENCE, COMPLICATIONS, AND SURVIVAL IN 70 PATIENTS WITH THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
    ECHT, DS
    ARMSTRONG, K
    SCHMIDT, P
    OYER, PE
    STINSON, EB
    WINKLE, RA
    [J]. CIRCULATION, 1985, 71 (02) : 289 - 296
  • [9] 6-YEAR CLINICAL-EXPERIENCE WITH THE AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
    EDEL, TB
    MALONEY, JD
    MOORE, S
    MCGUINN, WP
    GOHN, D
    WILLIAMS, D
    WILKOFF, BL
    MCCARTHY, P
    MORANT, VA
    PEARCE, G
    SIMMONS, TW
    TROHMAN, R
    FIRSTENBERG, M
    CASTLE, LW
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1991, 14 (11): : 1850 - 1854
  • [10] ANALYSIS OF DEATHS IN PATIENTS WITH AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
    EDEL, TB
    MALONEY, JD
    MOORE, SL
    MCALLISTER, H
    GOHN, D
    SHEWCHIK, JM
    ALEXANDER, L
    FIRSTENBERG, MS
    CASTLE, LW
    SIMMONS, TW
    WILKOFF, BL
    TROHMAN, R
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1992, 15 (01): : 60 - 70